Download PDF
Journal of Pediatric Biochemistry 2016; 06(04): 199-208
DOI: 10.1055/s-0037-1598638
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Biomarkers for Sleep Apnea

Michal Gur   *
1   Pediatric Pulmonology Institute and CF Center, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel
,
Yazeed Toukan   *
1   Pediatric Pulmonology Institute and CF Center, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel
2   Rappaport Faculty of Medicine, Technion–Israel Institute of Technology, Haifa, Israel
,
Lea Bentur
1   Pediatric Pulmonology Institute and CF Center, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel
2   Rappaport Faculty of Medicine, Technion–Israel Institute of Technology, Haifa, Israel
,
Fahed Hakim
1   Pediatric Pulmonology Institute and CF Center, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel
2   Rappaport Faculty of Medicine, Technion–Israel Institute of Technology, Haifa, Israel
› Author Affiliations
Further Information

Publication History

03 January 2017

08 January 2017

Publication Date:
14 February 2017 (online)

    Permissions and Reprints

Abstract

Obstructive sleep apnea (OSA) is a substantial medical problem with significant morbidity, both in the pediatric population and in adults. The gold standard for diagnosis and assessment of response to treatment has been overnight polysomnography. However, it is costly, time-consuming, and inconvenient to the patients. Thus, there is an emerging need for markers that would identify patients with OSA, especially those at risk for complications who require closer surveillance and more aggressive treatment. In recent years, a large number of studies have been conducted to search for the ideal biomarker in the blood and other body fluids, mainly urine, saliva, and exhaled breath. We present a literature review of current literature on biomarkers of OSA. We conclude that the ideal sole biomarker has not been found yet, but several markers have the potential to serve as screening tools; an array of markers, as well as analysis of epigenetic factors, could serve in diagnosis and in tailoring the best specific treatment for the single patient.

Keywords

biomarkers - sleep apnea - polysomnography

* These authors contributed equally to this study.


 

  • References

  • 1 Montesi SB, Bajwa EK, Malhotra A. Biomarkers of sleep apnea. Chest 2012; 142 (1) 239-245
    CrossrefPubMedGoogle Scholar
  • 2 Gozal D, Jortani S, Snow AB , et al. Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea. Am J Respir Crit Care Med 2009; 180 (12) 1253-1261
    CrossrefPubMedGoogle Scholar
  • 3 De Luca Canto G, Pachêco-Pereira C, Aydinoz S, Major PW, Flores-Mir C, Gozal D. Biomarkers associated with obstructive sleep apnea and morbidities: a scoping review. Sleep Med 2015; 16 (3) 347-357
    CrossrefPubMedGoogle Scholar
  • 4 Rosen CL, Larkin EK, Kirchner HL , et al. Prevalence and risk factors for sleep-disordered breathing in 8- to 11-year-old children: association with race and prematurity. J Pediatr 2003; 142 (4) 383-389
    CrossrefPubMedGoogle Scholar
  • 5 Kapur VK. Obstructive sleep apnea: diagnosis, epidemiology, and economics. Respir Care 2010; 55 (9) 1155-1167
    PubMedGoogle Scholar
  • 6 Kheirandish-Gozal L. What is “abnormal” in pediatric sleep?. Respir Care 2010; 55 (10) 1366-1374 , discussion 1374–1376
    PubMedGoogle Scholar
  • 7 Castell JV, Gómez-Lechón MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990; 12 (5) 1179-1186
    CrossrefPubMedGoogle Scholar
  • 8 Gozal D, Crabtree VM, Sans Capdevila O, Witcher LA, Kheirandish-Gozal L. C-reactive protein, obstructive sleep apnea, and cognitive dysfunction in school-aged children. Am J Respir Crit Care Med 2007; 176 (2) 188-193
    CrossrefPubMedGoogle Scholar
  • 9 Kritikou I, Basta M, Vgontzas AN , et al. Sleep apnoea, sleepiness, inflammation and insulin resistance in middle-aged males and females. Eur Respir J 2014; 43 (1) 145-155
    CrossrefPubMedGoogle Scholar
  • 10 Ryan S, Taylor CT, McNicholas WT. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2006; 174 (7) 824-830
    CrossrefPubMedGoogle Scholar
  • 11 Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 2000; 148 (2) 209-214
    CrossrefPubMedGoogle Scholar
  • 12 Guilleminault C, Kirisoglu C, Ohayon MM. C-reactive protein and sleep-disordered breathing. Sleep 2004; 27 (8) 1507-1511
    CrossrefPubMedGoogle Scholar
  • 13 Riha RL, Brander P, Vennelle M , et al. Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. Eur Respir J 2005; 26 (4) 673-678
    CrossrefPubMedGoogle Scholar
  • 14 Bhushan B, Guleria R, Misra A, Luthra K, Vikram NK. TNF-alpha gene polymorphism and TNF-alpha levels in obese Asian Indians with obstructive sleep apnea. Respir Med 2009; 103 (3) 386-392
    CrossrefPubMedGoogle Scholar
  • 15 Nadeem R, Molnar J, Madbouly EM , et al. Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 2013; 9 (10) 1003-1012
    PubMedGoogle Scholar
  • 16 Fornadi K, Lindner A, Czira ME , et al. Lack of association between objectively assessed sleep disorders and inflammatory markers among kidney transplant recipients. Int Urol Nephrol 2012; 44 (2) 607-617
    CrossrefPubMedGoogle Scholar
  • 17 Basoglu OK, Sarac F, Sarac S, Uluer H, Yilmaz C. Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thorac Med 2011; 6 (3) 120-125
    CrossrefPubMedGoogle Scholar
  • 18 Chin K, Ohi M, Kita H , et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996; 153 (6 Pt 1): 1972-1976
    CrossrefPubMedGoogle Scholar
  • 19 Shamsuzzaman A, Amin RS, Calvin AD, Davison D, Somers VK. Severity of obstructive sleep apnea is associated with elevated plasma fibrinogen in otherwise healthy patients. Sleep Breath 2014; 18 (4) 761-766
    CrossrefPubMedGoogle Scholar
  • 20 Kaditis AG, Alexopoulos EI, Kalampouka E , et al. Morning levels of fibrinogen in children with sleep-disordered breathing. Eur Respir J 2004; 24 (5) 790-797
    CrossrefPubMedGoogle Scholar
  • 21 Phillips CL, McEwen BJ, Morel-Kopp M-C , et al. Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover study. Thorax 2012; 67 (7) 639-644
    CrossrefPubMedGoogle Scholar
  • 22 Steiropoulos P, Papanas N, Nena E , et al. Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role?. Mediators Inflamm 2010; 2010: 675320 . Doi: 10.1155/2010/675320
    PubMedGoogle Scholar
  • 23 Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol 2010; 28 (1) 157-183
    CrossrefPubMedGoogle Scholar
  • 24 Ciccone MM, Scicchitano P, Zito A , et al. Correlation between inflammatory markers of atherosclerosis and carotid intima-media thickness in obstructive sleep apnea. Molecules 2014; 19 (2) 1651-1662
    CrossrefPubMedGoogle Scholar
  • 25 Kobukai Y, Koyama T, Watanabe H, Ito H. Morning pentraxin 3 levels reflect obstructive sleep apnea-related acute inflammation. J Appl Physiol (1985) 2014; 117 (10) 1141-1148
    CrossrefPubMedGoogle Scholar
  • 26 Yasunaga T, Ikeda S, Koga S , et al. Plasma pentraxin 3 is a more potent predictor of endothelial dysfunction than high-sensitive C-reactive protein. Int Heart J 2014; 55 (2) 160-164
    CrossrefPubMedGoogle Scholar
  • 27 Shen P, Han Y, Cai B, Wang Y. Decreased levels of serum nesfatin-1 in patients with obstructive sleep apnea syndrome. Sleep Breath 2015; 19 (2) 515-522
    CrossrefPubMedGoogle Scholar
  • 28 Ichimura A, Hirasawa A, Poulain-Godefroy O , et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 2012; 483 (7389): 350-354
    CrossrefPubMedGoogle Scholar
  • 29 Oh DY, Talukdar S, Bae EJ , et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010; 142 (5) 687-698
    CrossrefPubMedGoogle Scholar
  • 30 Gozal D, Kheirandish-Gozal L, Carreras A, Khalyfa A, Peris E. Obstructive sleep apnea and obesity are associated with reduced GPR 120 plasma levels in children. Sleep 2014; 37 (5) 935-941
    CrossrefPubMedGoogle Scholar
  • 31 Li W, Yu Z, Jiang C. Association of serum YKL-40 with the presence and severity of obstructive sleep apnea syndrome. Lab Med 2014; 45 (3) 220-225
    CrossrefPubMedGoogle Scholar
  • 32 Wang X, Xing G-H. Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome. Scand J Clin Lab Invest 2014; 74 (1) 74-78
    CrossrefPubMedGoogle Scholar
  • 33 Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol 2015; 4: 180-183
    CrossrefPubMedGoogle Scholar
  • 34 Liu H-G, Liu K, Zhou Y-N, Xu Y-J. Relationship between reduced nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene polymorphism and obstructive sleep apnea-hypopnea syndrome in the Chinese Han population. Chin Med J (Engl) 2009; 122 (12) 1369-1374
    PubMedGoogle Scholar
  • 35 Schulz R, Schmidt D, Blum A , et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000; 55 (12) 1046-1051
    CrossrefPubMedGoogle Scholar
  • 36 Wysocka E, Cofta S, Cymerys M, Gozdzik J, Torlinski L, Batura-Gabryel H. The impact of the sleep apnea syndrome on oxidant-antioxidant balance in the blood of overweight and obese patients. J Physiol Pharmacol 2008; 59 (Suppl 6): 761-769
    PubMedGoogle Scholar
  • 37 Alonso-Fernández A, García-Río F, Arias MA , et al. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax 2009; 64 (7) 581-586
    CrossrefPubMedGoogle Scholar
  • 38 Findley LJ, Boykin M, Fallon T, Belardinelli L. Plasma adenosine and hypoxemia in patients with sleep apnea. J Appl Physiol (1985) 1988; 64 (2) 556-561
    CrossrefPubMedGoogle Scholar
  • 39 Fletcher EC, Miller J, Schaaf JW, Fletcher JG. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 1987; 10 (1) 35-44
    PubMedGoogle Scholar
  • 40 Paci A, Marrone O, Lenzi S , et al. Endogenous digitalislike factors in obstructive sleep apnea. Hypertens Res 2000; 23 (Suppl): S87-S91
    CrossrefPubMedGoogle Scholar
  • 41 Lin SW, Tsai CN, Lee YS, Chu SF, Chen NH. Gene expression profiles in peripheral blood mononuclear cells of Asian obstructive sleep apnea patients. Biomed J 2014; 37 (2) 60-70
    CrossrefPubMedGoogle Scholar
  • 42 Kim J, Bhattacharjee R, Khalyfa A , et al. DNA methylation in inflammatory genes among children with obstructive sleep apnea. Am J Respir Crit Care Med 2012; 185 (3) 330-338
    CrossrefPubMedGoogle Scholar
  • 43 Kheirandish-Gozal L, Khalyfa A, Gozal D, Bhattacharjee R, Wang Y. Endothelial dysfunction in children with obstructive sleep apnea is associated with epigenetic changes in the eNOS gene. Chest 2013; 143 (4) 971-977
    CrossrefPubMedGoogle Scholar
  • 44 Khalyfa A, Bhushan B, Hegazi M , et al. Fatty-acid binding protein 4 gene variants and childhood obesity: potential implications for insulin sensitivity and CRP levels. Lipids Health Dis 2010; 9 (1) 18 . Doi: 10.1186/1476-511X-9-18
    CrossrefPubMedGoogle Scholar
  • 45 Bhushan B, Khalyfa A, Spruyt K , et al. Fatty-acid binding protein 4 gene polymorphisms and plasma levels in children with obstructive sleep apnea. Sleep Med 2011; 12 (7) 666-671
    CrossrefPubMedGoogle Scholar
  • 46 Khalyfa A, Kheirandish-Gozal L, Capdevila OS, Bhattacharjee R, Gozal D. Macrophage migration inhibitory factor gene polymorphisms and plasma levels in children with obstructive sleep apnea. Pediatr Pulmonol 2012; 47 (10) 1001-1011
    CrossrefPubMedGoogle Scholar
  • 47 Aronsohn RS, Whitmore H, Van Cauter E, Tasali E. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med 2010; 181 (5) 507-513
    CrossrefPubMedGoogle Scholar
  • 48 Papanas N, Steiropoulos P, Nena E , et al. HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men. Vasc Health Risk Manag 2009; 5: 751-756
    PubMedGoogle Scholar
  • 49 Gozal D, Sans Capdevila O, McLaughlin Crabtree V, Serpero LD, Witcher LA, Kheirandish-Gozal L. Plasma IGF-1 levels and cognitive dysfunction in children with obstructive sleep apnea. Sleep Med 2009; 10 (2) 167-173
    CrossrefPubMedGoogle Scholar
  • 50 Shah ZA, Jortani SA, Tauman R, Valdes Jr R, Gozal D. Serum proteomic patterns associated with sleep-disordered breathing in children. Pediatr Res 2006; 59 (3) 466-470
    CrossrefPubMedGoogle Scholar
  • 51 De Luca Canto G, Pachêco-Pereira C, Aydinoz S, Major PW, Flores-Mir C, Gozal D. Diagnostic capability of biological markers in assessment of obstructive sleep apnea: a systematic review and meta-analysis. J Clin Sleep Med 2015; 11 (1) 27-36
    PubMedGoogle Scholar
  • 52 Nelson DH, Sandberg AA, Palmer JG, Tyler FH. Blood levels of 17-hydroxycorticosteroids following the administration of adrenal steroids and their relation to levels of circulating leukocytes. J Clin Invest 1952; 31 (9) 843-849
    CrossrefPubMedGoogle Scholar
  • 53 Thomson SP, McMahon LJ, Nugent CA. Endogenous cortisol: a regulator of the number of lymphocytes in peripheral blood. Clin Immunol Immunopathol 1980; 17 (4) 506-514
    CrossrefPubMedGoogle Scholar
  • 54 Koseoglu HI, Altunkas F, Kanbay A, Doruk S, Etikan I, Demir O. Platelet-lymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome. J Thromb Thrombolysis 2015; 39 (2) 179-185
    CrossrefPubMedGoogle Scholar
  • 55 Kheirandish-Gozal L, Peris E, Gozal D. Vitamin D levels and obstructive sleep apnoea in children. Sleep Med 2014; 15 (4) 459-463
    CrossrefPubMedGoogle Scholar
  • 56 Villa MP, Supino MC, Fedeli S , et al. Urinary concentration of 8-isoprostane as marker of severity of pediatric OSAS. Sleep Breath 2014; 18 (4) 723-729
    CrossrefPubMedGoogle Scholar
  • 57 Montgomery-Downs HE, Krishna J, Roberts II LJ, Gozal D. Urinary F2-isoprostane metabolite levels in children with sleep-disordered breathing. Sleep Breath 2006; 10 (4) 211-215
    CrossrefPubMedGoogle Scholar
  • 58 Monneret D, Pepin J-L, Godin-Ribuot D , et al. Association of urinary 15-F2t-isoprostane level with oxygen desaturation and carotid intima-media thickness in nonobese sleep apnea patients. Free Radic Biol Med 2010; 48 (4) 619-625
    CrossrefPubMedGoogle Scholar
  • 59 Del Ben M, Fabiani M, Loffredo L , et al. Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment. BMC Pulm Med 2012; 12 (1) 36 . Doi: 10.1186/1471-2466-12-36
    CrossrefPubMedGoogle Scholar
  • 60 Stanke-Labesque F, Bäck M, Lefebvre B , et al. Increased urinary leukotriene E4 excretion in obstructive sleep apnea: effects of obesity and hypoxia. J Allergy Clin Immunol 2009; 124 (2) 364-370 , 370.e1–370.e2
    CrossrefPubMedGoogle Scholar
  • 61 Kaditis AG, Alexopoulos E, Chaidas K , et al. Urine concentrations of cysteinyl leukotrienes in children with obstructive sleep-disordered breathing. Chest 2009; 135 (6) 1496-1501
    CrossrefPubMedGoogle Scholar
  • 62 Arias MA, García-Río F, Alonso-Fernández A , et al. CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J 2008; 32 (4) 1009-1015
    CrossrefPubMedGoogle Scholar
  • 63 O'Driscoll DM, Horne RSC, Davey MJ , et al. Increased sympathetic activity in children with obstructive sleep apnea: cardiovascular implications. Sleep Med 2011; 12 (5) 483-488
    CrossrefPubMedGoogle Scholar
  • 64 Kaditis AG, Alexopoulos EI, Damani E , et al. Urine levels of catecholamines in Greek children with obstructive sleep-disordered breathing. Pediatr Pulmonol 2009; 44 (1) 38-45
    CrossrefPubMedGoogle Scholar
  • 65 Kelly A, Dougherty S, Cucchiara A, Marcus CL, Brooks LJ. Catecholamines, adiponectin, and insulin resistance as measured by HOMA in children with obstructive sleep apnea. Sleep 2010; 33 (9) 1185-1191
    CrossrefPubMedGoogle Scholar
  • 66 Kheirandish-Gozal L, McManus CJT, Kellermann GH, Samiei A, Gozal D. Urinary neurotransmitters are selectively altered in children with obstructive sleep apnea and predict cognitive morbidity. Chest 2013; 143 (6) 1576-1583
    CrossrefPubMedGoogle Scholar
  • 67 Lam JCM, Yan CSW, Lai AYK , et al. Determinants of daytime blood pressure in relation to obstructive sleep apnea in men. Lung 2009; 187 (5) 291-298
    CrossrefPubMedGoogle Scholar
  • 68 Pinto P, Bárbara C, Montserrat JM , et al. Effects of CPAP on nitrate and norepinephrine levels in severe and mild-moderate sleep apnea. BMC Pulm Med 2013; 13 (13) 13 . Doi: 10.1186/1471-2466-13-13
    CrossrefPubMedGoogle Scholar
  • 69 Sukegawa M, Noda A, Sugiura T , et al. Assessment of continuous positive airway pressure treatment in obstructive sleep apnea syndrome using 24-hour urinary catecholamines. Clin Cardiol 2005; 28 (11) 519-522
    CrossrefPubMedGoogle Scholar
  • 70 Minemura H, Akashiba T, Yamamoto H, Akahoshi T, Kosaka N, Horie T. Acute effects of nasal continuous positive airway pressure on 24-hour blood pressure and catecholamines in patients with obstructive sleep apnea. Intern Med 1998; 37 (12) 1009-1013
    CrossrefPubMedGoogle Scholar
  • 71 Phillips CL, Yang Q, Williams A , et al. The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnoea. J Sleep Res 2007; 16 (12) 217-225
    CrossrefPubMedGoogle Scholar
  • 72 Kohler M, Stoewhas A-C, Ayers L , et al. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med 2011; 184 (10) 1192-1199
    CrossrefPubMedGoogle Scholar
  • 73 Krishna J, Shah ZA, Merchant M, Klein JB, Gozal D. Urinary protein expression patterns in children with sleep-disordered breathing: preliminary findings. Sleep Med 2006; 7 (3) 221-227
    CrossrefPubMedGoogle Scholar
  • 74 Monneret D, Tamisier R, Ducros V , et al. The impact of obstructive sleep apnea on homocysteine and carotid remodeling in metabolic syndrome. Respir Physiol Neurobiol 2012; 180 (02/03) 298-304
    CrossrefPubMedGoogle Scholar
  • 75 Park CS, Guilleminault C, Hwang SH, Jeong JH, Park DS, Maeng JH. Correlation of salivary cortisol level with obstructive sleep apnea syndrome in pediatric subjects. Sleep Med 2013; 14 (10) 978-984
    CrossrefPubMedGoogle Scholar
  • 76 Jeong J-H, Guilleminault C, Park C-S , et al. Changes in salivary cortisol levels in pediatric patients with obstructive sleep apnea syndrome after adenotonsillectomy. Sleep Med 2014; 15 (6) 672-676
    CrossrefPubMedGoogle Scholar
  • 77 Patacchioli FR, Tabarrini A, Ghiciuc CM , et al. Salivary biomarkers of obstructive sleep apnea syndrome in children. Pediatr Pulmonol 2014; 49 (11) 1145-1152
    CrossrefPubMedGoogle Scholar
  • 78 Park CS, Guilleminault C, Park HJ , et al. Correlation of salivary alpha amylase level and adenotonsillar hypertrophy with sleep disordered breathing in pediatric subjects. J Clin Sleep Med 2014; 10 (5) 559-566
    PubMedGoogle Scholar
  • 79 Celec P, Hodosy J, Behuliak M , et al. Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure. Sleep Breath 2012; 16 (2) 393-398
    CrossrefPubMedGoogle Scholar
  • 80 Papaioannou I, Twigg GL, Kemp M , et al. Melatonin concentration as a marker of the circadian phase in patients with obstructive sleep apnoea. Sleep Med 2012; 13 (2) 167-171
    CrossrefPubMedGoogle Scholar
  • 81 Malakasioti G, Alexopoulos E, Befani C , et al. Oxidative stress and inflammatory markers in the exhaled breath condensate of children with OSA. Sleep Breath 2012; 16 (3) 703-708
    CrossrefPubMedGoogle Scholar
  • 82 Bikov A, Hull JH, Kunos L. Exhaled breath analysis, a simple tool to study the pathophysiology of obstructive sleep apnoea. Sleep Med Rev 2016; 27: 1-8
    CrossrefPubMedGoogle Scholar
  • 83 Biltagi MA, Maguid MA, Ghafar MA, Farid E. Correlation of 8-isoprostane, interleukin-6 and cardiac functions with clinical score in childhood obstructive sleep apnoea. Acta Paediatr 2008; 97 (10) 1397-1405
    CrossrefPubMedGoogle Scholar
  • 84 Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 2003; 124 (4) 1386-1392
    CrossrefPubMedGoogle Scholar
  • 85 Petrosyan M, Perraki E, Simoes D , et al. Exhaled breath markers in patients with obstructive sleep apnoea. Sleep Breath 2008; 12 (3) 207-215
    CrossrefPubMedGoogle Scholar
  • 86 Antonopoulou S, Loukides S, Papatheodorou G, Roussos C, Alchanatis M. Airway inflammation in obstructive sleep apnea: is leptin the missing link?. Respir Med 2008; 102 (10) 1399-1405
    CrossrefPubMedGoogle Scholar
  • 87 Li Y, Chongsuvivatwong V, Geater A, Liu A. Exhaled breath condensate cytokine level as a diagnostic tool for obstructive sleep apnea syndrome. Sleep Med 2009; 10 (1) 95-103
    CrossrefPubMedGoogle Scholar
  • 88 Vlasic V, Trifunovic J, Cepelak I, Nimac P, Topic RZ, Dodig S. Urates in exhaled breath condensate of children with obstructive sleep apnea. Biochem Med (Zagreb) 2011; 21 (2) 139-144
    PubMedGoogle Scholar
  • 89 Goldbart AD, Krishna J, Li RC, Serpero LD, Gozal D. Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome. Chest 2006; 130 (1) 143-148
    CrossrefPubMedGoogle Scholar
  • 90 Aihara K, Oga T, Chihara Y , et al. Analysis of systemic and airway inflammation in obstructive sleep apnea. Sleep Breath 2013; 17 (2) 597-604
    CrossrefPubMedGoogle Scholar
  • 91 Benedek P, Lázár Z, Bikov A, Kunos L, Katona G, Horváth I. Exhaled biomarker pattern is altered in children with obstructive sleep apnoea syndrome. Int J Pediatr Otorhinolaryngol 2013; 77 (8) 1244-1247
    CrossrefPubMedGoogle Scholar
  • 92 Bayrakli I, OztUrk O, Akman H. Investigation of acetone, butanol and carbon dioxide as new breath biomarkers for convenient and noninvasive diagnosis of obstructive sleep apnea syndrome. Biomed Chromatogr 2016; DOI: 10.1002/bmc.3757.
    PubMedGoogle Scholar
  • 93 Culla B, Guida G, Brussino L , et al. Increased oral nitric oxide in obstructive sleep apnoea. Respir Med 2010; 104 (2) 316-320
    CrossrefPubMedGoogle Scholar
  • 94 Gut G, Tauman R, Greenfeld M, Armoni-Domany K, Sivan Y. Nasal nitric oxide in sleep-disordered breathing in children. Sleep Breath 2016; 20 (1) 303-308
    CrossrefPubMedGoogle Scholar